Evidence map›Paper›PMID 33166321›Full record

ArticlePloS one2020

Molecular strategy for the direct detection and identification of human enteroviruses in clinical specimens associated with hand, foot and mouth disease.

Yonghong Zhou, Qi Qiu, Kaiwei Luo, Qiaohong Liao, Yu Li, Peng Cui, Lu Liang, Yibing Cheng, Lili Wang, Kai Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Yonghong ZhouSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
Qi QiuSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
Kaiwei LuoHunan Provincial Center for Disease Control and Prevention, Changsha, Hunan Province, China.
Qiaohong LiaoSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
Yu LiDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Centre for Disease Control and Prevention, Beijing, China.
Peng CuiSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
Lu LiangWest China School of Public Health, Sichuan University, Chengdu, China.
Yibing ChengHospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou, China.
Lili WangSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
Kai WangSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
Le Van TanOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
H Rogier van DoornOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID 0000-0002-9807-1821
Hongjie YuSchool of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.ORCID 0000-0002-6335-5648
Fudan University · CNChinese Center For Disease Control and Prevention · CNHunan Provincial Center for Disease Control and Prevention · CNOxford University Clinical Research Unit · VNSichuan University · CNUniversity of Oxford · GBZhengzhou University · CN

Funding

Virology &ImmunologyU19AI051915 · NIAID · NATIONAL CENTER FOR AIDS/STD CONTROL AND PREVENTION · PI SHAO, YIMING · 2002 to 2009
$21.6M
NIAID NIH HHS U19 AI051915Wellcome Trust 204904/Z/16/Z
6 · The paper itself

Abstract

backgroundDiseases caused by human enteroviruses (EVs) are a major global public health problem. Thus, the effective diagnosis of all human EVs infections and the monitoring of epidemiological and ecological dynamic changes are urgently needed.

methodsBased on two comprehensive virological surveillance systems of hand, foot and mouth disease (HFMD), real-time PCR and nested RT-PCR (RT-snPCR) methods based on the enteroviral VP1, VP4-VP2 and VP4 regions were designed to directly detect all human EVs serotypes in clinical specimens.

resultsThe results showed that the proposed serotyping strategy exhibit very high diagnostic efficiency (Study 1: 99.9%; Study 2: 89.5%), and the variance between the study was due to inclusion of the specific Coxsackie virus A6 (CVA6) real-time RT-PCR and VP4 RT-snPCR in Study 1 but not Study 2. Furthermore, only throat swabs were collected and analyzed in Study 2, whereas in Study 1, if a specific EV serotype was not identified in the primary stool sample, other sample types (rectal swab and throat swab) were further tested where available. During the study period from 2013 to 2018, CVA6 became one of the main HFMD causative agents, whereas the level of enterovirus A71 (EV-A71) declined in 2017.

conclusionThe findings of this study demonstrate the appropriate application of PCR methods and the combination of biological sample types that are useful for etiological studies and propose a molecular strategy for the direct detection of human EVs in clinical specimens associated with HFMD.

Indexed as

AdolescentCapsid ProteinsChildChild, PreschoolEnterovirus A, HumanFecesHand, Foot and Mouth DiseaseHumansInfantIntestinal MucosaMolecular Diagnostic TechniquesReal-Time Polymerase Chain ReactionRespiratory MucosaReverse Transcriptase Polymerase Chain ReactionSensitivity and SpecificityViral Structural ProteinsCapsid ProteinsViral Structural ProteinsVP1 protein, Foot-and-mouth disease virusVP4 protein, Foot-and-mouth disease virus

Identifiers

PMID33166321
PMCPMC7652283
OpenAlexW3101314274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.